Alex joined Pappas Capital in 2019, bringing with him twelve years of therapeutics equity research experience and six years of biopharma operating experience. Prior to joining Pappas, he was a Managing Director with BMO Capital Markets where he was a top-ranked senior equity research analyst responsible for pharmaceutical and biotechnology companies. In early 2019, Alex won the Starmine award as the #1 stock picker in pharmaceuticals. Alex began his career in the pharmaceuticals industry in 1999 with operating roles at Merck and Endo Pharmaceuticals, including positions in sales, market research, forecasting and product management.
Alex currently serves as an observer for BioAtla and previously served as a director for Curzion Pharmaceuticals.
University of Toronto (BSc in Cell and Molecular Biology)
Duke University Fuqua School of Business (MBA, Health Sector Management Concentration)